platoseedplatoseed
Software to launch and integrate genetics into clinical care
Nest is a lab-agnostic, comprehensive solution for organizations to launch and implement large-scale genomic programs. The platform includes the ability to triage, consent, and counsel patients for genetic testing, provide EMR-integrated clinical decision support for providers managing patients with genetic results, and manage patients’ clinical needs across the continuum of care.
Nest Genomics offers an AI-native genomics platform designed to identify, test, and manage genomic programs within healthcare systems. It aims to launch, coordinate, and scale genomic initiatives across labs, EHRs, and clinical workflows.
A lab-agnostic, EHR-integrated platform with SMART on FHIR and FHIR APIs, configurable test menus, and end-to-end care automation. It provides patient identification, clinical decision support, tailored education, and streamlined ordering/results delivery across multiple labs, plus program analytics to measure performance and outcomes. The system supports flexible routing to preferred labs, structured results storage, and scalable growth without re-platforming.
Who it’s for: Healthcare organizations (health systems, hospitals) seeking to deploy and scale genomic programs.
Backed by Y Combinator; HIPAA compliant; SOC 2 Type II; lab-agnostic; multiple healthcare organization references implied
I'm dedicated to increasing access to genetic information. My previous company Clear Genetics was acquired NVTA in 2019, where I led the Software and Data organization. I also founded MorNetware, which developed Genometer a software that screens 90% of Israeli pregnancies for ethnic-based carrier screening since 2005. I was an officer in the IDF Elite software unit and studied Biomedical Engineering for my BA M.Sc. I have an MBA from the Wharton Business School and am a 2-time Y Combinator Alum.
I'm a co-founder and COO of Nest Genomics (W22). Until recently, I led SaaS teams at Invitae (NVTA), a global genetics company. I was the co-founder and COO of ClearGenetics (W17, acquired by Invitae), which developed innovative software for integrating genetics into routine care. Before that, I held senior product roles at Twitter, SnappyTV and Google/Motorola. I'm a Mammram Alum, hold a Bachelor’s in Computer Science and MBA from Duke and Tel-Aviv University.
Formerly “Applied Genomics”, “Guide Genomics”, “Pepper Genomics” · why startups rename →
Unleashing the potential of DNA and RNA based therapies using AI
Personalized prevention using genetics and AI
